Katherine High

From 2014 to 2020, Dr. High held several key executive positions at Spark Therapeutics, Inc., a gene therapy company, including President, Head of Research and Development and Chief Scientific Officer. Prior to joining Spark, Dr. High was a Professor at the Perelman School of Medicine at the University of Pennsylvania and an Investigator at the Howard Hughes Medical Institute. Additionally, from 2004 to 2014, Dr. High served as the Director of the Center for Cellular and Molecular Therapeutics at Children’s Hospital of Philadelphia. Dr. High served a five-year term on the FDA Advisory Committee on Cell, Tissue and Gene Therapies, and was a past president of the American Society of Gene & Cell Therapy (ASGCT). She received her A.B. in chemistry from Harvard University, an M.D. from the University of North Carolina School of Medicine, a business certification from the University of North Carolina Business School Management Institute for Hospital Administrators and an M.A. from the University of Pennsylvania.